This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sery, T. W. Search for Related Content PubMed PubMed Citation Articles by Sery, T. W.

Photodynamic Killing of Retinoblastoma Cells with Hematoporphyrin and Light¹

The Wills Eye Research Institute, Philadelphia, Pennsylvania 19130

Hematoporphyrin and white light exerted a lethal effect on two cell lines of retinoblastoma cells. The lowest values of dye concentration and light exposure capable of killing an entire cell population were, respectively, 2 x 10^-5 M and 6 min exposure to an irradiance of 6.0 microwatts/sq mm. Cells exposed to light in the presence of the dye did not require lengthy incubation periods but were rapidly killed with increasing periods of light exposure. Cells washed free of the dye, however, required a minimum sensitizing period of 3.5 hr to achieve a value close to 100% cell death. An inhibitor of this photodynamic process was demonstrated in normal serum. When the concentration of either fetal calf serum, rabbit serum, or rabbit plasma was increased to 25% from a standard 10%, there was as much as a 100-fold greater requirement of hematoporphyrin concentration to produce the same lethal response. The suggested explanation for this phenomenon is a porphyrin-binding plasma factor, hemopexin, which is a natural ß-glycoprotein believed to be responsible for the transport of circulating porphyrins to the liver for their elimination. Retinoblastoma cells grow in suspension and thereby provide an excellent tool for study of photosensitive dyes, especially in the case of the rapidly growing Y79 cell line.

¹ This work was supported by Biomedical Research Support Grant RR 05510-13 of the NIH, by Grant EY 02131-01 and Training Grant EY 00084-05 of the National Eye Institute, and by The Eye Association for Research Support, Philadelphia, Pa. Presented in part at the Association for Research in Vision and Ophthalmology Meeting, Sarasota, Fla., May 1978.

Received 12/20/77. Accepted 10/ 6/78.

This article has been cited by other articles:

				H. Stephan, R. Boeloeni, A. Eggert, N. Bornfeld, and A. Schueler Photodynamic Therapy in Retinoblastoma: Effects of Verteporfin on Retinoblastoma Cell Lines Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3158 - 3163. [Abstract] [Full Text] [PDF]

				D. T. Tse, J. J. Dutton, T. A. Weingeist, V. M. Hermsen, and R. C. Kersten Hematoporphyrin Photoradiation Therapy for Intraocular and Orbital Malignant Melanoma Arch Ophthalmol, June 1, 1984; 102(6): 833 - 838. [Abstract] [PDF]

				R. A. Lewis, D. T. Tse, C. D. Phelps, and T. A. Weingeist Neovascular Glaucoma After Photoradiation Therapy for Uveal Melanoma Arch Ophthalmol, June 1, 1984; 102(6): 839 - 842. [Abstract] [PDF]

				L. H. S. Liu and C. Ni Hematoporphyrin Phototherapy for Experimental Intraocular Malignant Melanoma Arch Ophthalmol, June 1, 1983; 101(6): 901 - 903. [Abstract] [PDF]